KLARIBIN 125 mg/5 ml ; KLARIBIN 250 mg/5 ml


Suspension
scheduling status
S4
registration number
KLARIBIN 125 mg/5 ml 38/20.1.1/0176 ; KLARIBIN 250 mg/5 ml 38/20.1.1/0163
What KLARIBIN 125 mg/5 ml ; KLARIBIN 250 mg/5 ml contains
KLARIBIN 125 mg/5 ml Each 5 ml of constituted suspension contains: Clarithromycin 125 mg Sodium benzoate (as preservative) 0,2 % m/v KLARIBIN 250 mg/5 ml Each 5 ml of constituted suspension contains: Clarithromycin 250 mg Sodium benzoate (as preservative) 0,2 % m/v.
other ingredients
Alginic acid Aspartame Carbomer (Carbopol 974 P) Colloidal anhydrous silica Croscarmellose sodium Flavour Peppermint Flavour Tutti Frutti 051880 AP0551 Hydroxypropyl cellulose Hypromellose Isopropyl alcohol Macrogol 1500 (polyethylene glycol) Methacrylic acid -ethyl acrylate copolymer (1:1) Dispersion 30 % Microcrystalline cellulose Monosodium citrate Purified water Sodium benzoate Sodium chloride Sucrose Titanium dioxide Talc Xanthan Gum.
Therapeutic classification
Pharmacotherapeutic group: Antibacterial for systemic use, macrolide ATC code: J01FA09.
© 2026 SAHPRA. ALL RIGHTS RESERVED